Answers are grounded in this paper and cite their sources.
Introduction: Type 2 diabetes mellitus (DM), an endocrine disorder, has been implicated in many medical conditions including testosterone deficiency in men, known as hypogonadism, which has been documented for many years. Testosterone therapy in men with DM was testified to improve general health with no associated severe side effects. Aim: To assess the correlation of serum testosterone levels in patients with DM with cardiovascular risk factors. Materials and Methods: A total of 300 males (100 each group) visited an OPD/IPD at Department of Medicine, Santosh Medical College Ghaziabad, (U.P), India. Total testosterone (TT) and Bioavailable testosterone levels were measured using commercially available kits. Further, HbA1c, hsCRP, IL-6, plasma glucose, HDL, and triglyceride were measured. Finally correlation study was performed using Pearson’s Coefficient of correlation and multivariable logistic regression analysis. Results: The 300 males (100 in each group) were taken for the study. Except for group I, males in groups II and III have low levels of TT and bioavailable testosterone, with maximum decrease was observed in males with DM and Cardiovascular Disease (CVD). BMI, waist circumference, triglycerides, hsCRP, IL-6, glucose, and insulin were established to be considerably increased in group III with respect to group I. We found an overall positive correlation of TT, with body fat percent and HbA1c while negaitive corelation with Bioavailable testosterone and fasting blood sugar. Conclusions: From this, we can conclude that the level of testosterone plays a vital role in the development of CVD in diabetic males. Thus, with suitable interference, mortality, and morbidity related to diabetes can be prohibited.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: